397 related articles for article (PubMed ID: 23569056)
1. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.
Kanavos P; Ferrario A; Vandoros S; Anderson GF
Health Aff (Millwood); 2013 Apr; 32(4):753-61. PubMed ID: 23569056
[TBL] [Abstract][Full Text] [Related]
2. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
3. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
Raimond VC; Feldman WB; Rome BN; Kesselheim AS
Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664
[TBL] [Abstract][Full Text] [Related]
4. Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?
Sarnak DO; Squires D; Kuzmak G; Bishop S
Issue Brief (Commonw Fund); 2017 Oct; 2017():1-14. PubMed ID: 28990747
[TBL] [Abstract][Full Text] [Related]
5. An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries.
Morgan SG; Good CB; Leopold C; Kaltenboeck A; Bach PB; Wagner A
Health Policy; 2018 Sep; 122(9):1012-1017. PubMed ID: 30041827
[TBL] [Abstract][Full Text] [Related]
6. International health care spending.
Schieber GJ; Puollier JP
Health Aff (Millwood); 1986; 5(3):111-22. PubMed ID: 3098657
[TBL] [Abstract][Full Text] [Related]
7. Spending on medicines in Israel in an international context.
Sax P
Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
[TBL] [Abstract][Full Text] [Related]
8. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
Vogler S; Vitry A; Babar ZU
Lancet Oncol; 2016 Jan; 17(1):39-47. PubMed ID: 26670089
[TBL] [Abstract][Full Text] [Related]
9. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
Wineinger NE; Zhang Y; Topol EJ
JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
[TBL] [Abstract][Full Text] [Related]
10. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
Squires DA
Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22619775
[TBL] [Abstract][Full Text] [Related]
11. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
Squires DA
Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22582452
[TBL] [Abstract][Full Text] [Related]
12. Health Care Spending in the United States and Other High-Income Countries.
Papanicolas I; Woskie LR; Jha AK
JAMA; 2018 Mar; 319(10):1024-1039. PubMed ID: 29536101
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.
Rome BN; Feldman WB; Desai RJ; Kesselheim AS
JAMA Netw Open; 2021 May; 4(5):e218816. PubMed ID: 33944925
[TBL] [Abstract][Full Text] [Related]
14. Determinants of branded prescription medicine prices in OECD countries.
Kanavos PG; Vandoros S
Health Econ Policy Law; 2011 Jul; 6(3):337-67. PubMed ID: 21676345
[TBL] [Abstract][Full Text] [Related]
15. Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage.
Morgan SG; Leopold C; Wagner AK
CMAJ; 2017 Jun; 189(23):E794-E799. PubMed ID: 28606975
[TBL] [Abstract][Full Text] [Related]
16. It's the prices, stupid: why the United States is so different from other countries.
Anderson GF; Reinhardt UE; Hussey PS; Petrosyan V
Health Aff (Millwood); 2003; 22(3):89-105. PubMed ID: 12757275
[TBL] [Abstract][Full Text] [Related]
17. International prices and availability of pharmaceuticals in 2005.
Danzon PM; Furukawa MF
Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
[TBL] [Abstract][Full Text] [Related]
18. Prescription drug accessibility and affordability in the United States and abroad.
Morgan S; Kennedy J
Issue Brief (Commonw Fund); 2010 Jun; 89():1-12. PubMed ID: 20614652
[TBL] [Abstract][Full Text] [Related]
19. Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.
Clemans-Cope L; Epstein M; Banthin J; Kesselheim AS; Hwang TJ
JAMA Health Forum; 2023 Jan; 4(1):e225012. PubMed ID: 36637815
[TBL] [Abstract][Full Text] [Related]
20. Trends in Prescription Drug Spending Leading Up to Health Reform.
Blavin F; Waidmann T; Blumberg LJ; Roth J
Med Care Res Rev; 2014 Aug; 71(4):416-32. PubMed ID: 24830379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
